Provider [Proveedor]
QP20-19 Pharmacy Benefit Exclusion for Ultomiris (ravulizumab-cwvz) IV Injection
Fecha de entrada en vigencia del programa: 13 de marzo de 2019
Resultados de documentos y formularios
Mostrando 2641 - 2650 de 3159 resultados
Provider [Proveedor]
P21R1-19 Update: Reminder Regarding Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Pre-certification Requirements
Fecha de entrada en vigencia del programa: 01 de marzo de 2019
Provider [Proveedor]
P6R1-19 Update: Delay in Process Change for Requesting Precertification for Skilled Nursing Facility, Long Term Acute Care and Inpatient Rehabilitation Admissions
Fecha de entrada en vigencia del programa: 01 de marzo de 2019
Provider [Proveedor]
P28-19 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Members – eviCore Healthcare Utilization Management Program
Fecha de entrada en vigencia del programa: 01 de marzo de 2019
Provider [Proveedor]
P25-19 Medicare Advantage PPO Network Sharing Frequently Asked Questions
Fecha de entrada en vigencia del programa: 01 de marzo de 2019
Provider [Proveedor]
P29-19 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Members – eviCore Healthcare Utilization Management Program
Fecha de entrada en vigencia del programa: 01 de marzo de 2019
Provider [Proveedor]
P23-19 Prior Authorization Start Date for Urgent and Non-Urgent Preservice Requests
Fecha de entrada en vigencia del programa: 01 de marzo de 2019
Provider [Proveedor]
P27-19 Required Use of Authorization Portal to Submit Preservice Inpatient and Outpatient Prior Authorization and PAN Requests
Fecha de entrada en vigencia del programa: 01 de marzo de 2019
Provider [Proveedor]
P31-19 Medicare Crossover Process Change Effective During Second Quarter 2019
Fecha de entrada en vigencia del programa: 01 de marzo de 2019
Provider [Proveedor]
P30-19 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization, Notification, and Medical Policy Requirements
Fecha de entrada en vigencia del programa: 01 de marzo de 2019